A new study suggests that using human papillomavirus (HPV)-based screening could eliminate cervical cancer by 2040. This is based on findings published in the Canadian Medical Association Journal (CMAJ). The study highlights the effectiveness of HPV-based screening over the traditional Pap test, presenting a transformative approach to cervical cancer prevention.

The Impact of HPV on Cervical Cancer: HPV is a significant cause of cervical cancer. There are nine high-risk HPV strains responsible for over 90% of cervical cancer cases worldwide. The World Health Organization (WHO) and the Canadian Partnership Against Cancer (CPAC) have set targets to eradicate cervical cancer by 2040. They define elimination as having an annual rate of less than 4 cases per 100,000 women.

Traditional Pap Test vs. HPV-Based Screening: For decades, the Pap test has been the primary tool for cervical cancer screening. However, HPV-based screening offers better accuracy in detecting cervical precancer. Moreover, HPV-based screening can be performed on samples collected by the patients themselves, making it more accessible and potentially increasing screening uptake.

"The option for self-collection may also reduce barriers to access and increase screening uptake among those who are never- or underscreened," writes Dr. Reka Pataky, lead author and researcher at the Canadian Centre for Applied Research in Cancer Control and BC Cancer, Vancouver, BC.

Modelling Study and Projections: Researchers used CPAC’s OncoSim-Cervical model to develop scenarios that would help British Columbia achieve its targets for eliminating cervical cancer. Here are the key projections:

1. Current Pap Testing: Without changes to HPV vaccination rates or screening participation, BC would not reach the target of 4 cases per 100,000 until 2045.
2. HPV-Based Screening: Implementing HPV-based screening could help BC achieve this target by 2034, potentially preventing more than 900 cases of cervical cancer by 2050.

Addressing Concerns and Strategic Implementation: There are concerns about the increased demand for colposcopies and precancer treatments that might arise from implementing HPV-based screening. The study authors suggest phased-in HPV testing by age could help manage this burden on healthcare systems.

"Screening programs across Canada need to implement HPV-based cervix screening in strategic and innovative ways that increase access to screening services, enhance timely follow-up and treatment, and reduce health disparities across the population," they conclude.

Increasing Accessibility and Addressing Disparities: Dr. Shannon Charlebois, medical editor at CMAJ, and Dr. Sarah Kean, a gynecologic oncologist at the University of Manitoba, emphasize the need to address equity in cervical cancer screening. They note that invasive cervical cancer disproportionately affects equity-seeking populations, including:

- 2SLGBTQI+ people
- Immigrants
- Those with disabilities
- Black and Indigenous people
- Victims of sexual trauma
- Females living with HIV

These groups are less likely to be screened, yet they are most at risk. Self-sampling, which evidence shows is as accurate as physician-collected samples, can significantly increase access to cervical cancer screening for these underserved populations.

"If Canada is to eliminate cervical cancer, which is entirely possible, every health system across the country should integrate self-sampling into their cervical cancer screening program," Charlebois and Kean write.

The Future of Cervical Cancer Screening: The study highlights the potential of HPV-based screening to revolutionize cervical cancer prevention. By adopting this method, British Columbia could lead the way in eliminating cervical cancer by 2040. This approach not only promises better accuracy but also enhances accessibility, making it a pivotal step in public health.

The shift from the traditional Pap test to HPV-based screening marks a significant advancement in the fight against cervical cancer. By 2040, British Columbia could potentially eliminate cervical cancer, thanks to the enhanced accuracy and accessibility of HPV-based screening. This transformative approach showcases the importance of innovation in healthcare and the need to address disparities in access to ensure all populations benefit from these advancements.

As Canada moves towards this goal, integrating self-sampling into cervical cancer screening programs across all health systems will be crucial. This strategy not only aligns with the targets set by WHO and CPAC but also ensures that the most vulnerable populations receive the care they need, ultimately paving the way for a future free of cervical cancer.